Elevated serum RAS p21 is an independent prognostic factor in metastatic breast cancer

[11] Rusch M(2017)Loss of RasGAP tumor suppressors underlies the aggressive nature of luminal B breast cancers Cancer Discov 7 202-247

[12] Biankin AV(2014)Fragment N2, a caspase-3-generated RasGAP fragment, inhibits breast cancer metastatic progression Int J Cancer 135 242-72

[13] Waddell N(1986)Structure and function of p21 ras proteins Gene Amplif Anal 4 53-78

[14] Kassahn KS(2002)Association between the ras p21 oncoprotein in blood samples and breast cancer Cancer Lett 185 71-1266

[15] Gingras MC(1995)Expression of ras p21, p53 and c-erbB-2 in advanced breast cancer and response to first line hormonal therapy Br J Cancer 72 1259-5293

[16] Muthuswamy LB(1987)Prognostic significance of the expression of a ras protein with a molecular weight of 21,000 by human breast cancer Cancer Res 47 5290-169

[17] Johns AL(1991)The H-ras oncogene product p21 and prognosis in human breast cancer Breast Cancer Res Treat 17 161-62

[18] Miller DK(1994)Evaluation of oncogene-related proteins in serum Cancer Epidemiol Biomark Prev 3 57-587

[19] Wilson PJ(1990)Production and characterization of anti-RAS p21 monoclonal antibodies Hybridoma 9 573-319

[20] Patch AM(2007)Circulating oncoproteins HER2/neu, EGFR and CAIX (MN) as novel cancer biomarkers Expert Rev Mol Diagn 7 309-414

[11] Rusch M(2017)Loss of RasGAP tumor suppressors underlies the aggressive nature of luminal B breast cancers Cancer Discov 7 202-247

[12] Biankin AV(2014)Fragment N2, a caspase-3-generated RasGAP fragment, inhibits breast cancer metastatic progression Int J Cancer 135 242-72

[13] Waddell N(1986)Structure and function of p21 ras proteins Gene Amplif Anal 4 53-78

[14] Kassahn KS(2002)Association between the ras p21 oncoprotein in blood samples and breast cancer Cancer Lett 185 71-1266

[15] Gingras MC(1995)Expression of ras p21, p53 and c-erbB-2 in advanced breast cancer and response to first line hormonal therapy Br J Cancer 72 1259-5293

[16] Muthuswamy LB(1987)Prognostic significance of the expression of a ras protein with a molecular weight of 21,000 by human breast cancer Cancer Res 47 5290-169

[17] Johns AL(1991)The H-ras oncogene product p21 and prognosis in human breast cancer Breast Cancer Res Treat 17 161-62

[18] Miller DK(1994)Evaluation of oncogene-related proteins in serum Cancer Epidemiol Biomark Prev 3 57-587

[19] Wilson PJ(1990)Production and characterization of anti-RAS p21 monoclonal antibodies Hybridoma 9 573-319

[20] Patch AM(2007)Circulating oncoproteins HER2/neu, EGFR and CAIX (MN) as novel cancer biomarkers Expert Rev Mol Diagn 7 309-414